{
    "hands_on_practices": [
        {
            "introduction": "The distinction between a high-risk precancerous lesion and a true carcinoma is one of the most fundamental concepts in pathology. This exercise explores the critical boundary between high-grade dysplasia and intramucosal carcinoma, where neoplastic cells first breach the basement membrane. Understanding this distinction is not merely academic; it hinges on the microanatomy of the colonic wall, specifically the absence of functional lymphatic vessels in the lamina propria, which explains why carcinoma confined to the mucosa (pTis) has a negligible risk of metastasis . This problem will challenge you to apply these core principles to differentiate these entities and justify their different clinical implications.",
            "id": "4348748",
            "problem": "A $65$-year-old patient undergoes endoscopic polypectomy for a $2.0$ $\\mathrm{cm}$ sessile colonic polyp. Hematoxylin and Eosin (H&E) stained sections show a conventional tubular-villous adenoma with foci of marked cytologic atypia: enlarged hyperchromatic nuclei with prominent nucleoli, increased mitotic figures, luminal necrosis, and complex cribriform glandular architecture. In a separate area, there are small irregular clusters and occasional single neoplastic cells infiltrating the lamina propria with a fibroinflammatory stromal response; the muscularis mucosae is intact, and no submucosa is present in the submitted tissue. Immunohistochemistry is not performed.\n\nStarting from core definitions and well-tested observations in gastrointestinal pathology (mucosal microanatomy: epithelium, basement membrane, lamina propria, muscularis mucosae, submucosa; definition of invasion as penetration beyond the basement membrane into supporting stroma; reliance of metastatic spread on access to lymphatic or vascular channels; and the Tumor-Node-Metastasis (TNM) staging rules that define pT1 as invasion into submucosa and pTis as carcinoma confined to mucosa), determine which statements correctly distinguish high-grade dysplasia from intramucosal carcinoma in colorectal adenomas and justify why intramucosal carcinoma is not considered invasive for staging and metastatic risk.\n\nSelect all that apply.\n\nA. The demonstrated small clusters and single neoplastic cells infiltrating beyond the basement membrane into the lamina propria constitute intramucosal carcinoma; high-grade dysplasia remains architecturally confined above the basement membrane without stromal invasion. In Tumor-Node-Metastasis (TNM), such mucosa-confined invasion is staged pTis.\n\nB. Because the colonic lamina propria lacks functional lymphatic channels, intramucosal carcinoma has negligible risk of nodal metastasis unless the submucosa is invaded; therefore, it is not considered “invasive carcinoma” in colorectal cancer staging.\n\nC. Crossing the muscularis mucosae into the submucosa does not alter staging from pTis; carcinomas remain intramucosal until there is invasion into the muscularis propria.\n\nD. High-grade dysplasia can be diagnosed when neoplastic glands penetrate the muscularis mucosae if cytologic atypia is marked; desmoplasia is never required to diagnose invasion within the mucosa.\n\nE. The presence of abundant lymphatic vessels within the lamina propria explains the metastatic potential of intramucosal carcinoma; therefore, intramucosal carcinoma is staged pT1.\n\nF. A key morphologic discriminator is stromal invasion with disorganized small clusters and single cells accompanied by a fibroinflammatory (desmoplastic) reaction, favoring intramucosal carcinoma; by contrast, pure cribriforming and luminal necrosis without stromal infiltration favors high-grade dysplasia.",
            "solution": "The problem statement is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\n\n- **Patient Demographics:** $65$-year-old.\n- **Procedure:** Endoscopic polypectomy.\n- **Gross Pathology:** $2.0$ $\\mathrm{cm}$ sessile colonic polyp.\n- **Histopathology (H&E):**\n    - Diagnosis: Conventional tubular-villous adenoma.\n    - Features of High-Grade Dysplasia: Marked cytologic atypia (enlarged hyperchromatic nuclei with prominent nucleoli, increased mitotic figures), luminal necrosis, and complex cribriform glandular architecture.\n    - Features of Invasion: In a separate area, small irregular clusters and occasional single neoplastic cells infiltrating the lamina propria with a fibroinflammatory stromal response.\n    - Anatomic Extent: The muscularis mucosae is intact; no submucosa is present in the submitted tissue.\n- **Ancillary Studies:** Immunohistochemistry is not performed.\n- **Core Principles for Analysis:**\n    - Mucosal microanatomy: epithelium, basement membrane, lamina propria, muscularis mucosae, submucosa.\n    - Definition of invasion: penetration beyond the basement membrane into supporting stroma.\n    - Metastatic spread mechanism: requires access to lymphatic or vascular channels.\n    - TNM Staging Rules: pT1 is defined as invasion into the submucosa; pTis is carcinoma confined to the mucosa.\n\n### Step 2: Validate Using Extracted Givens\n\n- **Scientifically Grounded:** The problem describes a classic case of a colorectal adenoma with progression to intramucosal carcinoma. The histological descriptions, anatomical landmarks (lamina propria, muscularis mucosae), and staging principles (TNM: pTis, pT1) are all fundamental and accurate concepts in gastrointestinal pathology and oncology. The scenario is scientifically sound.\n- **Well-Posed:** The problem provides a detailed case and a clear set of established principles. The question asks to use these principles to evaluate statements distinguishing high-grade dysplasia from intramucosal carcinoma and to explain the clinical significance. This is a well-defined task.\n- **Objective:** The language is technical, precise, and objective, using standard pathological terminology. It is free of subjective or ambiguous phrasing.\n- **Other Flaws:** The problem is self-contained, internally consistent, and realistic. It presents a standard diagnostic and conceptual challenge in pathology. No flaws are identified.\n\n### Step 3: Verdict and Action\n\n- The problem is **valid**. A solution will be derived based on the provided information and principles.\n\n### Derivation and Option Analysis\n\nThe core of the problem is to distinguish between high-grade dysplasia (HGD) and intramucosal carcinoma (IMC) and to understand the biological and staging implications.\n\n**First Principles:**\n1.  **Anatomy of the Colonic Mucosa:** The mucosa is the innermost layer of the colon wall and comprises three sublayers: the epithelium (where carcinoma originates), the lamina propria (a layer of connective tissue, capillaries, and small immune cells supporting the epithelium), and the muscularis mucosae (a thin muscle layer that separates the mucosa from the submucosa).\n2.  **Definition of Dysplasia vs. Carcinoma:** Dysplasia, including HGD, refers to neoplastic proliferation of cells that exhibit cytologic and architectural atypia but remain confined by the basement membrane to the glandular structures. Even complex architectural arrangements like back-to-back glands or cribriform structures are classified as HGD if there is no invasion. Invasion is the defining feature of carcinoma, occurring when neoplastic cells breach the basement membrane and infiltrate the underlying stroma (in this case, the lamina propria).\n3.  **Definition of Intramucosal Carcinoma (IMC):** This is carcinoma where invasion is limited to the lamina propria, without breaching the muscularis mucosae. The case describes this perfectly: \"small irregular clusters and occasional single neoplastic cells infiltrating the lamina propria.\"\n4.  **TNM Staging:** The American Joint Committee on Cancer (AJCC) TNM staging system for colorectal cancer defines pathologic tumor stages as follows:\n    -   pTis (Carcinoma in situ): Intraepithelial carcinoma or invasion of the lamina propria (intramucosal carcinoma). The key is that the tumor has not penetrated the muscularis mucosae to reach the submucosa.\n    -   pT1: Tumor invades the submucosa.\n5.  **Metastatic Potential:** For a tumor to metastasize via the lymphatic system, it must gain access to lymphatic vessels. In the colon, large, functional lymphatic channels that facilitate nodal metastasis are predominantly located within the submucosa and deeper layers. The lamina propria contains only capillaries and very small, sparse lymphatics, rendering the risk of lymph node metastasis from a purely intramucosal carcinoma negligible (estimated at $<1\\%$).\n\nBased on these principles, the lesion described has features of both HGD (\"complex cribriform glandular architecture\") and IMC (\"neoplastic cells infiltrating the lamina propria\"). The presence of invasion into the lamina propria makes the final diagnosis intramucosal carcinoma (arising in an adenoma). Because the muscularis mucosae is intact, it is staged as pTis.\n\n### Evaluation of Options\n\n**A. The demonstrated small clusters and single neoplastic cells infiltrating beyond the basement membrane into the lamina propria constitute intramucosal carcinoma; high-grade dysplasia remains architecturally confined above the basement membrane without stromal invasion. In Tumor-Node-Metastasis (TNM), such mucosa-confined invasion is staged pTis.**\nThis statement accurately defines intramucosal carcinoma as invasion into the lamina propria, correctly contrasting it with high-grade dysplasia, which is non-invasive. It also correctly states that invasion confined to the mucosa (i.e., intramucosal carcinoma) is staged as pTis. This aligns perfectly with the definitions provided and standard pathological practice.\n**Verdict: Correct**\n\n**B. Because the colonic lamina propria lacks functional lymphatic channels, intramucosal carcinoma has negligible risk of nodal metastasis unless the submucosa is invaded; therefore, it is not considered “invasive carcinoma” in colorectal cancer staging.**\nThis statement provides the correct biological rationale for the staging of IMC. The paucity of functional lymphatics in the lamina propria is the reason for the extremely low metastatic risk of IMC. While \"invasive\" from a purely histological perspective (breach of basement membrane), it is not considered \"invasive\" for the purpose of T-staging beyond pTis because it lacks significant metastatic potential. This lack of potential is why it is grouped with intraepithelial lesions as pTis and not staged as pT1. The reasoning is sound.\n**Verdict: Correct**\n\n**C. Crossing the muscularis mucosae into the submucosa does not alter staging from pTis; carcinomas remain intramucosal until there is invasion into the muscularis propria.**\nThis statement is factually incorrect. The boundary between pTis and pT1 is precisely the muscularis mucosae. Invasion *through* the muscularis mucosae *into* the submucosa defines a pT1 carcinoma. The statement that carcinomas remain intramucosal until they invade the muscularis propria (a pT2 lesion) is also false.\n**Verdict: Incorrect**\n\n**D. High-grade dysplasia can be diagnosed when neoplastic glands penetrate the muscularis mucosae if cytologic atypia is marked; desmoplasia is never required to diagnose invasion within the mucosa.**\nThe first part of this statement is fundamentally wrong. By definition, penetration of the muscularis mucosae constitutes, at a minimum, a pT1 invasive adenocarcinoma. High-grade dysplasia is a non-invasive lesion confined to the epithelium and its basement membrane. The second clause, \"desmoplasia is never required to diagnose invasion within the mucosa,\" is technically true—stromal infiltration by single cells or small clusters is sufficient evidence of invasion even without a desmoplastic response—but it cannot rescue a statement with a critically flawed premise.\n**Verdict: Incorrect**\n\n**E. The presence of abundant lymphatic vessels within the lamina propria explains the metastatic potential of intramucosal carcinoma; therefore, intramucosal carcinoma is staged pT1.**\nThis statement is incorrect on multiple fronts. The premise, \"abundant lymphatic vessels within the lamina propria,\" is factually false. As explained in the analysis for option B, the lamina propria is notable for its *lack* of significant lymphatics. Consequently, intramucosal carcinoma has negligible, not significant, metastatic potential. Finally, because of this, it is staged as pTis, not pT1. The entire statement is the opposite of the accepted pathophysiology.\n**Verdict: Incorrect**\n\n**F. A key morphologic discriminator is stromal invasion with disorganized small clusters and single cells accompanied by a fibroinflammatory (desmoplastic) reaction, favoring intramucosal carcinoma; by contrast, pure cribriforming and luminal necrosis without stromal infiltration favors high-grade dysplasia.**\nThis statement provides an excellent and accurate summary of the key histologic features that distinguish IMC from HGD. Invasion into the lamina propria, often characterized by a haphazard arrangement of single cells and small glands with an associated stromal reaction (as seen in the case), is the hallmark of IMC. Conversely, complex architectural atypia (like cribriforming) and cytologic atypia (like necrosis), when contained within the original glandular confines without invading the stroma, are classic features of HGD.\n**Verdict: Correct**",
            "answer": "$$\\boxed{ABF}$$"
        },
        {
            "introduction": "Once a diagnosis of invasive cancer is established, the next crucial step is to determine its extent, a process known as staging. The Tumor, Node, Metastasis (TNM) system provides a globally recognized framework for classifying a tumor's anatomical spread, which is essential for determining prognosis and guiding therapy. This hands-on practice asks you to act as part of an oncology team, translating detailed histopathologic findings from a rectal cancer resection into the precise language of the TNM system . By systematically determining the T, N, and M categories, you will learn how raw data from the laboratory is synthesized into a final cancer stage that directly impacts patient management.",
            "id": "5195504",
            "problem": "A patient with primary rectal adenocarcinoma undergoes total mesorectal excision. The histopathology report documents tumor invasion through the muscularis propria into the perirectal fat. Lymph node assessment shows $18$ regional nodes examined, with $4$ positive for metastatic carcinoma. Staging imaging excludes distant metastasis, thus $M0$ is established. Using the American Joint Committee on Cancer (AJCC) Eighth Edition Tumor Node Metastasis (TNM) framework and its stage group definitions for rectal cancer, proceed as follows:\n\n- From foundational definitions of $T$, $N$, and $M$ in colorectal cancer, assign the appropriate $T$ and $N$ categories.\n- From the AJCC stage group logic for rectal cancer with $M0$, determine the stage group (Roman numeral with subclass letter).\n\nTo provide a single numerical final answer, encode the stage group with the following index function. Let the Roman stage numeral be mapped to $I_{\\mathrm{Roman}} \\in \\{1,2,3,4\\}$ corresponding to $\\{\\mathrm{I}, \\mathrm{II}, \\mathrm{III}, \\mathrm{IV}\\}$, and let the subclass letter mapping be $L \\in \\{1,2,3\\}$ corresponding to $\\{\\mathrm{A}, \\mathrm{B}, \\mathrm{C}\\}$. Define the stage index\n$$\n\\mathcal{I}(T,N,M) = 10\\,I_{\\mathrm{Roman}} + L.\n$$\nCompute $\\mathcal{I}(T,N,M)$ for this patient. No rounding is required. Express the final answer as a unitless real number.",
            "solution": "The problem as stated is valid. It is scientifically grounded, well-posed, and objective. The problem is based on the standardized American Joint Committee on Cancer (AJCC) Eighth Edition TNM staging system, which is a cornerstone of modern oncology and systemic surgery. The provided histopathological and clinical findings are specific, consistent, and sufficient to determine a unique stage and calculate the requested index. The definitions and mappings are clear and unambiguous.\n\nThe solution proceeds by systematically determining each component of the TNM classification and then deriving the final stage group and index.\n\n**1. T (Primary Tumor) Category Determination**\n\nThe histopathology report states: \"tumor invasion through the muscularis propria into the perirectal fat.\" We consult the AJCC $8^{th}$ Edition definitions for colorectal cancer T categories:\n- $T1$: Tumor invades submucosa.\n- $T2$: Tumor invades muscularis propria.\n- $T3$: Tumor invades through the muscularis propria into the perirectal tissues.\n- $T4a$: Tumor penetrates to the surface of the visceral peritoneum.\n- $T4b$: Tumor directly invades or adheres to other organs or structures.\n\nThe description precisely matches the definition of a $T3$ tumor. Therefore, the T category is $T3$.\n\n**2. N (Regional Lymph Nodes) Category Determination**\n\nThe report documents: \"$18$ regional nodes examined, with $4$ positive for metastatic carcinoma.\" The AJCC $8^{th}$ Edition definitions for N categories in colorectal cancer are based on the number of positive regional nodes:\n- $N0$: No regional lymph node metastasis.\n- $N1$: Metastasis in $1-3$ regional lymph nodes.\n  - $N1a$: Metastasis in $1$ regional lymph node.\n  - $N1b$: Metastasis in $2-3$ regional lymph nodes.\n  - $N1c$: Tumor deposit(s) present, but no nodal metastasis.\n- $N2$: Metastasis in $4$ or more regional lymph nodes.\n  - $N2a$: Metastasis in $4-6$ regional lymph nodes.\n  - $N2b$: Metastasis in $7$ or more regional lymph nodes.\n\nThe finding of $4$ positive nodes falls squarely within the definition of the $N2a$ category. The total number of nodes examined, $18$, is well above the minimum of $12$ required for adequate staging. Therefore, the N category is $N2a$.\n\n**3. M (Distant Metastasis) Category Determination**\n\nThe problem explicitly states that imaging excluded distant metastasis. This corresponds to the $M0$ category.\n\n**4. Anatomic Stage Group Determination**\n\nWith the complete TNM classification of $T3$, $N2a$, $M0$, we determine the anatomic stage group using the AJCC $8^{th}$ Edition table for rectal cancer. The relevant portion of the staging logic is:\n- Stage IIIA: $T1-T2$ $N1/N1c$ $M0$; $T1$ $N2a$ $M0$\n- Stage IIIB: $T3-T4a$ $N1/N1c$ $M0$; $T2-T3$ $N2a$ $M0$; $T1-T2$ $N2b$ $M0$\n- Stage IIIC: $T4a$ $N2a$ $M0$; $T3-T4a$ $N2b$ $M0$; $T4b$ $N1-N2$ $M0$\n\nThe patient's classification, $T3$ $N2a$ $M0$, matches a criterion for Stage IIIB. Therefore, the patient's cancer is Stage IIIB.\n\n**5. Computation of the Stage Index**\n\nThe problem defines an index function $\\mathcal{I}(T,N,M) = 10\\,I_{\\mathrm{Roman}} + L$. We must map the determined stage, IIIB, to the numerical parameters.\n- The Roman numeral is III, which maps to $I_{\\mathrm{Roman}} = 3$.\n- The subclass letter is B, which maps to $L = 2$ (since A maps to $1$, B to $2$, and C to $3$).\n\nSubstituting these values into the index function:\n$$\n\\mathcal{I} = 10 \\times 3 + 2\n$$\n$$\n\\mathcal{I} = 30 + 2 = 32\n$$\n\nThe stage index for this patient is $32$.",
            "answer": "$$\\boxed{32}$$"
        },
        {
            "introduction": "Pathology plays a vital role not only in diagnosing disease but also in preventing it. In the context of colorectal cancer, the findings from a polypectomy directly inform a patient's future risk and guide surveillance strategies. This practice places you in a clinical setting where you must use the details from a pathology report—specifically the number, size, and histology of resected polyps—to make an evidence-based decision . This exercise demonstrates the powerful link between microscopic analysis and preventive medicine, as you apply established risk stratification guidelines to recommend a personalized surveillance interval for a patient.",
            "id": "4348717",
            "problem": "A $56$-year-old patient undergoes a high-quality screening colonoscopy (cecal intubation documented, Boston Bowel Preparation Scale (BBPS) score $8$ of $9$) with complete cold-snare resection of all visualized polyps. Histopathology reports a polyp burden of $3$ tubular adenomas each measuring $5$–$7$ mm (no villous component, no high-grade dysplasia) and $1$ sessile serrated lesion measuring $12$ mm (no cytologic dysplasia). The patient has no personal or family history of colorectal cancer and no inflammatory bowel disease. Based on established post-polypectomy risk strata that use polyp number, size, and histology to guide surveillance, and assuming complete resection and adequate quality, what is the recommended post-polypectomy surveillance interval?\n\nA. $1$ year\nB. $3$ years\nC. $5$ years\nD. $7$–$10$ years",
            "solution": "### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe problem statement provides the following information:\n-   Patient age: $56$-year-old\n-   Procedure: high-quality screening colonoscopy\n-   Quality metrics: cecal intubation documented, Boston Bowel Preparation Scale (BBPS) score $8$ of $9$\n-   Procedure outcome: complete cold-snare resection of all visualized polyps\n-   Histopathology finding 1: $3$ tubular adenomas, each measuring $5$–$7$ mm, with no villous component and no high-grade dysplasia\n-   Histopathology finding 2: $1$ sessile serrated lesion (SSL) measuring $12$ mm, with no cytologic dysplasia\n-   Patient history: no personal or family history of colorectal cancer, no inflammatory bowel disease\n-   Underlying premise: The recommendation should be based on established post-polypectomy risk strata, assuming complete resection and adequate quality.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem is assessed against the required criteria:\n\n-   **Scientifically Grounded**: The problem is based on established principles of gastroenterology and pathology, specifically the surveillance of colorectal neoplasia. The terminology used (tubular adenoma, sessile serrated lesion, dysplasia, BBPS) is standard and scientifically valid. The request to use \"established post-polypectomy risk strata\" directly refers to evidence-based clinical practice guidelines, such as those from the U.S. Multi-Society Task Force on Colorectal Cancer (USMSTF). The scenario is a common and realistic clinical case. The problem is scientifically sound.\n\n-   **Well-Posed**: The problem provides a comprehensive set of clinical data—patient age, procedure quality, and precise polyp characteristics (number, size, histology). These are the exact parameters used in clinical guidelines to determine surveillance intervals. The question asks for a single recommended interval, which can be uniquely determined by applying the standard risk stratification algorithm from current guidelines. The problem is well-posed.\n\n-   **Objective**: The problem statement is composed entirely of objective, quantifiable data and standardized medical terminology. There are no subjective statements, opinions, or ambiguities in the description of the clinical findings.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. It is scientifically grounded, well-posed, objective, and contains sufficient information to derive a definitive answer based on established medical guidelines. The solution process may proceed.\n\n### Principle-Based Derivation\n\nThe recommended post-polypectomy surveillance interval is determined by stratifying the patient's risk of developing subsequent advanced neoplasia. This stratification is based on the findings of the index colonoscopy, primarily the number, size, and histology of the resected polyps. The most current and widely accepted guidelines in the United States are the 2020 recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer (USMSTF). The derivation will be based on these guidelines.\n\nThe patient's findings must be categorized according to the USMSTF risk strata:\n\n1.  **Tubular Adenomas**: The patient has $3$ tubular adenomas, each measuring between $5$ mm and $7$ mm. According to the 2020 USMSTF guidelines, the presence of $3$ to $10$ adenomas, regardless of size (as long as they are not large enough to fall into another high-risk category), places a patient in a higher-risk category. Specifically, this finding alone warrants a surveillance interval of $3$ years.\n\n2.  **Sessile Serrated Lesion (SSL)**: The patient has $1$ sessile serrated lesion measuring $12$ mm. The guidelines specify that an SSL measuring $\\ge 10$ mm is a high-risk finding. An SSL with cytologic dysplasia is also a high-risk finding, but even without dysplasia, size alone is a sufficient criterion. This patient's $12$ mm SSL therefore independently qualifies as a high-risk finding, warranting a surveillance interval of $3$ years.\n\nWhen a patient presents with multiple findings, the most conservative recommendation (i.e., the shortest surveillance interval) dictated by any single finding is adopted. In this case, the patient has two distinct findings, each of which independently places them in the high-risk stratum for which a $3$-year surveillance interval is recommended:\n-   Finding A: $3$ tubular adenomas $\\implies$ $3$-year interval.\n-   Finding B: $1$ SSL measuring $12$ mm ($\\ge 10$ mm) $\\implies$ $3$-year interval.\n\nBoth findings consistently point to the same recommendation. The high quality of the colonoscopy (BBPS $8/9$) and the explicit statement of complete resection confirm that a routine surveillance interval is appropriate, rather than an earlier follow-up to check for residual polyp tissue (which might be indicated for a piecemeal resection of a very large polyp, typically $\\ge 20$ mm). Therefore, the recommended post-polypectomy surveillance interval is $3$ years.\n\n### Option-by-Option Analysis\n\n**A. $1$ year**\nThis interval is generally reserved for special circumstances, such as the piecemeal resection of a large polyp ($\\ge 20$ mm) to verify complete eradication, or in cases of a very high polyp burden ($>10$ adenomas) where a familial polyposis syndrome is suspected and requires close monitoring while genetic assessment is underway. The problem states complete resection of polyps, the largest being $12$ mm, and a total polyp count of $4$. Therefore, a $1$-year interval is not indicated by standard guidelines.\n**Verdict: Incorrect**\n\n**B. $3$ years**\nThis interval is recommended for patients with findings that place them at high risk for future advanced neoplasia. According to the 2020 USMSTF guidelines, high-risk findings include having $3$–$10$ adenomas or having a sessile serrated lesion $\\ge 10$ mm. This patient's findings include both ($3$ adenomas and one $12$ mm SSL). Hence, a $3$-year surveillance interval is the correct recommendation.\n**Verdict: Correct**\n\n**C. $5$ years**\nA $5$-year interval is typically recommended for patients with intermediate-risk findings, which, under the 2020 USMSTF guidelines, specifically includes patients with sessile serrated lesions that are small ($<10$ mm) and lack dysplasia. This patient's findings (3 adenomas and a large SSL) exceed this risk category.\n**Verdict: Incorrect**\n\n**D. $7$–$10$ years**\nThis longer interval is recommended for patients with low-risk findings, defined as having only $1$ or $2$ small adenomas ($<10$ mm). The patient in this case has a total of $4$ polyps, including $3$ adenomas and a large SSL, which places them in a much higher risk category.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}